126 related articles for article (PubMed ID: 11289048)
1. A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo.
Manchem VP; Goldfine ID; Kohanski RA; Cristobal CP; Lum RT; Schow SR; Shi S; Spevak WR; Laborde E; Toavs DK; Villar HO; Wick MM; Kozlowski MR
Diabetes; 2001 Apr; 50(4):824-30. PubMed ID: 11289048
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.
Sakoda H; Ogihara T; Anai M; Funaki M; Inukai K; Katagiri H; Fukushima Y; Onishi Y; Ono H; Fujishiro M; Kikuchi M; Oka Y; Asano T
Diabetes; 2000 Oct; 49(10):1700-8. PubMed ID: 11016454
[TBL] [Abstract][Full Text] [Related]
3. Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells.
Li M; Youngren JF; Manchem VP; Kozlowski M; Zhang BB; Maddux BA; Goldfine ID
Diabetes; 2001 Oct; 50(10):2323-8. PubMed ID: 11574415
[TBL] [Abstract][Full Text] [Related]
4. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
[TBL] [Abstract][Full Text] [Related]
5. Antihyperglycemic mechanism of M16209, an antidiabetic agent, in 3T3-L1 adipocytes.
Murakami N; Inoue G; Okamoto M; Yoshimasa Y; Kohno S; Hayashi T; Kato K; Kuzuya H; Nakao K
Life Sci; 1997; 60(20):1821-31. PubMed ID: 9150422
[TBL] [Abstract][Full Text] [Related]
6. The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake.
Isakoff SJ; Taha C; Rose E; Marcusohn J; Klip A; Skolnik EY
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10247-51. PubMed ID: 7479761
[TBL] [Abstract][Full Text] [Related]
7. Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment.
Ross SA; Chen X; Hope HR; Sun S; McMahon EG; Broschat K; Gulve EA
Biochem Biophys Res Commun; 2000 Jul; 273(3):1033-41. PubMed ID: 10891367
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor (PDGF) stimulates glucose transport in 3T3-L1 adipocytes overexpressing PDGF receptor by a pathway independent of insulin receptor substrates.
Whiteman EL; Chen JJ; Birnbaum MJ
Endocrinology; 2003 Sep; 144(9):3811-20. PubMed ID: 12933652
[TBL] [Abstract][Full Text] [Related]
9. Effects of cell-permeable ceramides and tumor necrosis factor-alpha on insulin signaling and glucose uptake in 3T3-L1 adipocytes.
Wang CN; O'Brien L; Brindley DN
Diabetes; 1998 Jan; 47(1):24-31. PubMed ID: 9421370
[TBL] [Abstract][Full Text] [Related]
10. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.
Worrall DS; Olefsky JM
Mol Endocrinol; 2002 Feb; 16(2):378-89. PubMed ID: 11818508
[TBL] [Abstract][Full Text] [Related]
11. Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators.
Li M; Youngren JF; Dunaif A; Goldfine ID; Maddux BA; Zhang BB; Evans JL
J Clin Endocrinol Metab; 2002 Sep; 87(9):4088-93. PubMed ID: 12213853
[TBL] [Abstract][Full Text] [Related]
12. Substrates of semicarbazide-sensitive amine oxidase co-operate with vanadate to stimulate tyrosine phosphorylation of insulin-receptor-substrate proteins, phosphoinositide 3-kinase activity and GLUT4 translocation in adipose cells.
Enrique-Tarancón G; Castan I; Morin N; Marti L; Abella A; Camps M; Casamitjana R; Palacín M; Testar X; Degerman E; Carpéné C; Zorzano A
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):171-80. PubMed ID: 10926841
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a small molecule insulin receptor activator.
Salituro GM; Pelaez F; Zhang BB
Recent Prog Horm Res; 2001; 56():107-26. PubMed ID: 11237209
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes.
Hardy RW; Gupta KB; McDonald JM; Williford J; Wells A
Endocrinology; 1995 Feb; 136(2):431-9. PubMed ID: 7835273
[TBL] [Abstract][Full Text] [Related]
15. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
16. The HIV protease inhibitor nelfinavir induces insulin resistance and increases basal lipolysis in 3T3-L1 adipocytes.
Rudich A; Vanounou S; Riesenberg K; Porat M; Tirosh A; Harman-Boehm I; Greenberg AS; Schlaeffer F; Bashan N
Diabetes; 2001 Jun; 50(6):1425-31. PubMed ID: 11375344
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo prevention of HIV protease inhibitor-induced insulin resistance by a novel small molecule insulin receptor activator.
Cheng M; Chen S; Schow SR; Manchem VP; Spevak WR; Cristobal CP; Shi S; Macsata RW; Lum RT; Goldfine ID; Keck JG
J Cell Biochem; 2004 Aug; 92(6):1234-45. PubMed ID: 15258906
[TBL] [Abstract][Full Text] [Related]
18. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation.
Moon B; Kwan JJ; Duddy N; Sweeney G; Begum N
Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E106-15. PubMed ID: 12618360
[TBL] [Abstract][Full Text] [Related]
19. A novel T608R missense mutation in insulin receptor substrate-1 identified in a subject with type 2 diabetes impairs metabolic insulin signaling.
Esposito DL; Li Y; Vanni C; Mammarella S; Veschi S; Della Loggia F; Mariani-Costantini R; Battista P; Quon MJ; Cama A
J Clin Endocrinol Metab; 2003 Apr; 88(4):1468-75. PubMed ID: 12679424
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the insulin receptor substrate-1 with insulin-responsive deoxyglucose transport in 3T3-L1 adipocytes.
Rice KM; Garner CW
Biochem Biophys Res Commun; 1994 Jan; 198(2):523-30. PubMed ID: 7507665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
